GBX2 Antibodies

Santa Cruz Biotechnology offers a broad range of GBX2 monoclonal antibodies for research applications. GBX2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GBX2, a member of the homeobox gene family, plays a crucial role in the regulation of gene expression during embryonic development and is involved in the differentiation of various tissues. GBX2 expression has been extensively studied in cancer research, where it has been implicated in tumorigenesis and metastasis, making it a significant target for therapeutic interventions. Understanding GBX2 function provides essential insights into developmental biology and disease mechanisms. Researchers worldwide utilize GBX2 monoclonal antibodies to advance their studies in embryonic development, tissue differentiation, and cancer biology. The specificity and reliability of GBX2 monoclonal antibodies enable precise detection and analysis of GBX2 expression patterns. Santa Cruz Biotechnology monoclonal antibodies for GBX2 continue to support breakthrough discoveries in developmental biology and cancer research.